Not losing weight on Mounjaro: reasons for a plateau
If Mounjaro seems not to be working or the scale has stalled, timing, measurement, eating, sleep, other medicines or a medical issue may need review.
Patient stories
This video shares a patient's breakthrough after years of frustrating, unproductive attempts to lose weight across different unmonitored diets. Under personalized clinical care, she achieved her very first substantial breakthrough, shedding 6.5 kg in four weeks to decrease from 95.5 kg to 89 kg. Notably, during the final week alone, body scans confirmed the loss of two full kilograms of pure adipose tissue. This steady metabolic progress was accomplished strictly on a conservative initial dose without adverse gastrointestinal complications, demonstrating that tailored clinical oversight overcomes metabolic resistance where unguided dieting repeatedly falls short.
This video follows a patient who had tried several approaches without sustained loss, then lost 6.5 kg in one month, moving from 95.5 kg to 89 kg. It explores breaking diet resistance through the idea that a plateau can have different drivers and needs review rather than one assumed explanation.
During the final week, follow-up described a 2 kg fat reduction, achieved on a small starting dose without escalation or troublesome gastrointestinal symptoms in her case. This gives context to a diet plateau, but it does not show that one dose or treatment solves the problem for everyone.
For pure fat burning progress, read the reasons for a Mounjaro plateau and realistic expectations for Mounjaro results. For protecting muscle while fat falls, the muscle-protection guide covers nutrition, activity and follow-up. Moving from 95.5 kg to 89 kg after earlier attempts shows why breaking a plateau needs attention to timing, measurements and response rather than one ready-made explanation. The final fat follow-up added information beyond scale weight, but it remains a reading from one case at one time.
Possible drivers include timing, measurement, eating, sleep, other medicines or a medical issue, as well as a slower early response. In the video, the patient progressed after previous attempts, but her story does not explain every plateau. See the plateau and weight-loss guide.
In this case, the patient lost 6.5 kg on a small starting dose without escalation during the month shown. Response is individual, so the result is not a rule and the dose should not be changed without the clinician. Follow-up considers weight, fat and symptoms together.
That figure was reported in this patient’s follow-up and is not an expected rate for everyone. Fat estimates are affected by measurement conditions and timing, so the clinician should read the trend alongside weight and symptoms rather than rely on one week or direct comparison.
Muscle preservation involves adequate food, suitable protein, appropriate activity and follow-up of strength and body composition according to the person’s health. The video reports fat loss but does not provide an individual plan. See the muscle-protection guide.
If Mounjaro seems not to be working or the scale has stalled, timing, measurement, eating, sleep, other medicines or a medical issue may need review.
When might tirzepatide affect appetite and weight, and how should progress at 4, 12 and 20 weeks be read? A realistic guide to trial averages and individual results.
Weight loss is not a race to the lowest number. Learn how adequate food, suitable protein, resistance exercise and strength follow-up can help preserve muscle.
Patient Success Story: Losing 32 Kilos With Clinical Nutrition
Discover more
Belly Mesotherapy: Losing 11 cm in Two Sessions
Discover more
First Dose Results: Losing Body Fat and Increasing Muscle
Discover more
Losing 10 kg Fat: Hormonal Nutrition and Mesotherapy
Discover more
Mounjaro Patient Story: Losing 4 kg in Two Weeks
Discover more
Mounjaro First Week Results: Visceral Fat and Cravings
Discover more
Booking ahead is required. Patients are seen in order of arrival.